URINE TOXICOLOGY AS AN OUTCOME MEASURE IN DRUG ABUSE CLINICAL TRIALS: MUST EVERY SAMPLE BE ANALYZED?
Furkejuvvon:
COMPTON, P.A., ET AL., URINE TOXICOLOGY AS AN OUTCOME MEASURE IN DRUG ABUSE CLINICAL TRIALS: MUST EVERY SAMPLE BE ANALYZED?. JOURNAL OF ADDICTIVE DISEASES, Vol. 15, no. 2 (1996), p. 85-92.
Ref.
48982
Sajádat:
SIIS R.926
Palabras clave:
Análisis clínicos, Crítica, Drogodependencias, Utilización de servicios
Análisis clínicos, Crítica, Drogodependencias, Utilización de servicios
Geahča maid: URINE TOXICOLOGY AS AN OUTCOME MEASURE IN DRUG ABUSE CLINICAL TRIALS: MUST EVERY SAMPLE BE ANALYZED?
- MEASURING OUTCOME IN COCAINE CLINICAL TRIALS: A COMPARISON OF SWEAT PATCHES WITH URINE TOXICOLOGY AND PARTICIPANT SELF-REPORT
- URINE TOXOCOLOGY SAMPLES IN COCAINE TREATMENT TRIALS: HOW MANY NEED TO BE TESTED?
- TALK IS CHEAP: MEASURING DRINKING OUTCOMES IN CLINICAL TRIALS
- DETECTION TIME FOR SELECTED DRUGS IN URINE. EN: CLINICAL GUIDELINES AND PROCEDURES FOR THE USE OF METHADONE IN THE MAINTENANCE TREATMENT OF OPIOID DEPENDENCE
- PREVALENCE OF ILLICIT DRUGS DETECTED IN THE URINE OF WOMEN OF CHILDBEARING AGE IN ALABAMA PUBLIC HEALTH CLINICS
- UTILIZATION OF PLASMA AND URINE METHADONE CONCENTRATIONS TO OPTIMIZE TREATMENT IN MAINTENANCE CLINICS: I. MEASUREMENT TECHNIQUES FOR A CLINICAL SETTING